Natco Pharma receives USFDA approval for Nitroglycerin Sublingual Tablet
Natco Pharma has received final ANDA nod from USFDA for chest pain tablets through its marketing partner Alvogen. The drug Nitroglycerin Sublingual Tablets in strengths […]
Natco
Natco Pharma launches Posanat – antifungal injection
Natco Pharma has launched generic version of Posaconazole Injection, 300 mg/16.7ml, under its brand POSANAT. It may be noted, the drug is available for the […]
Natco Pharma launches generic version of Tenofovir Alafenamide in India
Natco Pharma has launched a generic version of Tenofovir Alafenamide, which is used to treat chronic Hepatitis B in India. The company is one of […]
Natco Pharma plans expansion programme in Manali
Natco Pharma is planning to expand its production unit in Vaikadu village in Manali near Chennai in Tamil Nadu. The project involves expanding bulk drug […]
Natco Pharma receives USFDA approval for Vidaza
Natco Pharma Ltd has got the final USFDA approval for the generic version of Vidaza (Azacitidine for injection, 100 mg per vial), single-dose vial. Natco […]
Natco Pharma to expand its Mekaguda plant
Natco Pharma is planning to expand its Mekaguda plant in Ranga Reddy district of Telangana with an investment of Rs. 4800 million. The project involves […]
Natco receives USFDA approval for Armodafinil
Natco Pharma has received final USFDA approval for generic Armodafinil tablets, used as wakefulness promoting agent. The company plans to market the same in US […]